Analyst Reco. Sartorius Stedim Biotech

Equities

Market Closed - Euronext Paris Other stock markets 09:05:08 26/04/2024 pm IST			5-day change	1st Jan Change
208.3 ^EUR	+2.41%		+3.84%	-13.03%

23/04	SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating	ZD
22/04	Sartorius Stedim: in the red with brokerage comments	CF

SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating	23/04	ZD
Sartorius Stedim: in the red with brokerage comments	22/04	CF
UBS Cuts Sartorius Stedim Biotech PT, Maintains at Neutral	22/04	MT
SARTORIUS STEDIM BIOTECH : Q1 24: A few positives despite the top-line miss	22/04
SARTORIUS STEDIM : UBS reduces target price	22/04	CF
SARTORIUS STEDIM BIOTECH : Jefferies remains its Buy rating	12/03	ZD
Berenberg: Sartorius Stedim Investors Await 'Several Strong Quarters' for Confidence Boost	16/02	MT
SARTORIUS STEDIM BIOTECH : FY23: Updated mid-term outlook offers much-valued ‘certainty’	30/01
SARTORIUS STEDIM : UBS raises its target price	29/01	CF
Sartorius thwarted by 21-day line - despite HSBC recommendation	10/01	DP
JPMORGAN : Sartorius outlook likely to be share price driver	02/01	DP
SARTORIUS STEDIM BIOTECH : Opinion change, from Buy to Add	19/12
Sartorius continues to slide - low since April 2020	23/23/23	DP
Sartorius and subsidiary recover - JPMorgan praises biotech orders	19/23/19	DP
SARTORIUS STEDIM BIOTECH : Disappointing preliminary Q3 23 puts mid-term outlook in question	17/23/17
Profit warning weighs heavily on Sartorius and subsidiary Stedim	13/23/13	DP
SARTORIUS STEDIM BIOTECH : Jefferies reiterates its Buy rating	29/23/29	ZD
Chinese headwinds could be more severe than expected	22/23/22
German Stocks Extend Losses Amid Rate Jitters Ahead of Monetary Policy Week	08/23/08	MT
SARTORIUS STEDIM BIOTECH : Jefferies gives a Buy rating	06/23/06	ZD

No results for this search

SARTORIUS STEDIM BIOTECH : Q1 24: A few positives despite the top-line miss

April 22, 2024 at 05:26 pm IST